BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19249943)

  • 1. Warfarin and pharmacogenomic testing: what would Pascal do?
    Teagarden JR
    Pharmacotherapy; 2009 Mar; 29(3):245-7. PubMed ID: 19249943
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenomic testing for warfarin dosing: we are ready now.
    Wu AH
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1483-5. PubMed ID: 19954308
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathology consultation on warfarin pharmacogenetic testing.
    Stack G;
    Am J Clin Pathol; 2011 Jan; 135(1):13-9. PubMed ID: 21173120
    [No Abstract]   [Full Text] [Related]  

  • 4. Using pharmacogenetics in real time to guide warfarin initiation: a clinician update.
    Carlquist JF; Anderson JL
    Circulation; 2011 Dec; 124(23):2554-9. PubMed ID: 22144632
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic testing for warfarin dosing? Not yet ready for prime time.
    Bussey HI; Wittkowsky AK; Hylek EM; Walker MB
    Pharmacotherapy; 2008 Feb; 28(2):141-3. PubMed ID: 18225960
    [No Abstract]   [Full Text] [Related]  

  • 6. Refining the use of warfarin through genetic testing.
    Lee SC
    Int Angiol; 2008 Aug; 27(4):271-3. PubMed ID: 18677287
    [No Abstract]   [Full Text] [Related]  

  • 7. Warfarin pharmacogenetics: ready for clinical utility?
    Baudhuin LM
    Clin Lab Sci; 2009; 22(3):151-5. PubMed ID: 19827409
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic help for a blood-thinner balancing act? There's little evidence yet that a genetic test improves the safety of warfarin.
    Harv Heart Lett; 2007 Dec; 18(4):1-2. PubMed ID: 18219801
    [No Abstract]   [Full Text] [Related]  

  • 9. The long and winding road to warfarin pharmacogenetic testing.
    Ginsburg GS; Voora D
    J Am Coll Cardiol; 2010 Jun; 55(25):2813-5. PubMed ID: 20579536
    [No Abstract]   [Full Text] [Related]  

  • 10. [Application of warfarin pharmacogenetics].
    Tomek A; Mat'oska V; Kumstýrfová T; Táborský L
    Vnitr Lek; 2009 Jun; 55(6):565-9. PubMed ID: 19662888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic-based dosing of warfarin.
    Med Lett Drugs Ther; 2008 May; 50(1286):39-40. PubMed ID: 18487958
    [No Abstract]   [Full Text] [Related]  

  • 12. Is a "pharmacogenomic algorithm" helpful for adjusting the initial dose of warfarin in patients to be treated by warfarin therapy?
    Goto S
    Circ J; 2010 May; 74(5):850-1. PubMed ID: 20424335
    [No Abstract]   [Full Text] [Related]  

  • 13. Warfarin monitoring woes: a glimmer of hope with pharmacogenomics.
    Beier MT
    J Am Med Dir Assoc; 2008 Mar; 9(3):199-200. PubMed ID: 18294604
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimization of warfarin dose by population-specific pharmacogenomic algorithm.
    Pavani A; Naushad SM; Rupasree Y; Kumar TR; Malempati AR; Pinjala RK; Mishra RC; Kutala VK
    Pharmacogenomics J; 2012 Aug; 12(4):306-11. PubMed ID: 21358752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of the relative effects of VKORC1 and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients.
    Meckley LM; Wittkowsky AK; Rieder MJ; Rettie AE; Veenstra DL
    Thromb Haemost; 2008 Aug; 100(2):229-39. PubMed ID: 18690342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic pharmacogenetic models in anticoagulation therapy.
    Bon Homme M; Reynolds KK; Valdes R; Linder MW
    Clin Lab Med; 2008 Dec; 28(4):539-52. PubMed ID: 19059061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomic considerations for customizing warfarin therapy in the orthopedic patient.
    Rhee S; Walsh K; Lewis D; Davis G; Smith KM
    Orthopedics; 2010 Nov; 33(11):828. PubMed ID: 21053849
    [No Abstract]   [Full Text] [Related]  

  • 18. Dosing anticoagulant therapy with coumarin drugs: is genotyping clinically useful? No.
    Mannucci PM; Spreafico M; Peyvandi F
    J Thromb Haemost; 2008 Sep; 6(9):1450-2. PubMed ID: 18627441
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical interest of point-of-care pharmacogenomic testing: clopidogrel behind warfarin.
    Shahabi P; Siest G; Visvikis-Siest S
    Pharmacogenomics; 2012 Aug; 13(11):1215-8. PubMed ID: 22920390
    [No Abstract]   [Full Text] [Related]  

  • 20. Warfarin dose requirement for patients with both VKORC1 3673A/A and CYP2C9*3/*3 genotypes.
    Fukuda T; Tanabe T; Ohno M; Tougou K; Fujio Y; Azuma J; Yamamoto I; Takeda A
    Clin Pharmacol Ther; 2006 Nov; 80(5):553-4. PubMed ID: 17112813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.